Literature DB >> 26154936

Epidemiology of biopsy-proven glomerulonephritis in Queensland adults.

Dev Jegatheesan1,2, Karthik Nath2,3, Reza Reyaldeen2,3, Goutham Sivasuthan2, George T John1, Leo Francis1, Mohana Rajmokan4, Dwarakanathan Ranganathan1.   

Abstract

AIM: There is a paucity of data pertaining to the incidence of biopsy-proven glomerulonephritis (GN) in Australia. This retrospective study aims to review the data from all adult native renal biopsies performed in the state of Queensland from 2002 to 2011--comparing results with centres from across the world.
METHODS: Pathology reports of 3697 adult native kidney biopsies were reviewed, of which 2048 had GN diagnoses. Age, gender, clinical indication and histopathology findings were compared.
RESULTS: The average age at biopsy was 48 ± 17 years. Male preponderance was noted overall (∼60%), with lupus nephritis being the only individual GN with female predilection. The average rate of biopsy was 12.04 per hundred thousand people per year (php/yr). Nephrotic and nephritic syndromes comprised approximately 75% of all clinical indications that lead to GN diagnoses. IgA nephropathy (1.41 php/yr) was the most common primary GN followed by focal segmental glomerulosclerosis (1.02 php/yr) and crescentic GN (0.73 php/yr). Diabetic nephropathy (0.84 php/yr), lupus nephritis (0.69 php/yr) and amyloidosis (0.19 php/yr) were the most commonly identified secondary GN.
CONCLUSION: IgA nephropathy is the predominant primary GN in Queensland, and nephrotic syndrome the most common indication for a renal biopsy. While crescentic GN incidence has significantly increased with time, focal segmental glomerulosclerosis incidence has not shown any trend. Incidence of GN overall appears to increase with age. The annual rate of biopsy in this study appears lower than previously published in an Australian population.
© 2015 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  Australia; Queensland; epidemiology; glomerulonephritis; nephritic

Mesh:

Year:  2016        PMID: 26154936     DOI: 10.1111/nep.12559

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  14 in total

1.  Adalimumab-induced IgA nephropathy.

Authors:  Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  A Global Evolutionary Trend of the Frequency of Primary Glomerulonephritis over the Past Four Decades.

Authors:  Keng Thye Woo; Choong Meng Chan; Cynthia Lim; Jason Choo; Yok Mooi Chin; Esther Wei Ling Teng; Irene Mok; Jia Liang Kwek; Alwin H L Loh; Hui Lin Choong; Han Kim Tan; Grace S L Lee; Evan Lee; Kok Seng Wong; Puay Hoon Tan; Marjorie Foo
Journal:  Kidney Dis (Basel)       Date:  2019-06-11

3.  MMP2 and MMP9 associate with crescentic glomerulonephritis.

Authors:  Tessa M Phillips; Mitali Fadia; Tom N Lea-Henry; Jonathan Smiles; Giles D Walters; Simon H Jiang
Journal:  Clin Kidney J       Date:  2016-12-26

4.  Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.

Authors:  Živile Riispere; Anne Kuudeberg; Elviira Seppet; Kristin Sepp; Madis Ilmoja; Merike Luman; Külli Kõlvald; Asta Auerbach; Mai Ots-Rosenberg
Journal:  BMC Nephrol       Date:  2017-03-14       Impact factor: 2.388

5.  Clinicopathologic correlations of renal biopsy findings from northeast China: A 10-year retrospective study.

Authors:  Sensen Su; Jinyu Yu; Yue Wang; Yu Wang; Jia Li; Zhonggao Xu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Changing Frequency of Glomerular Diseases in Western Saudi Arabia: A 26-Year Experience.

Authors:  Sawsan Mohammad Jalalah
Journal:  J Microsc Ultrastruct       Date:  2020-05-08

7.  The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two Decades.

Authors:  Keng Thye Woo; Choong Meng Chan; Cynthia Lim; Jason Choo; Yoke Mooi Chin; Esther Wei Ling Teng; Irene Mok; Jia Liang Kwek; Chieh Suai Tan; Hui Zhuan Tan; Alwin H L Loh; Hui Lin Choong; Han Kim Tan; Grace S L Lee; Evan Lee; Kok Seng Wong; Puay Hoon Tan; Marjorie Foo
Journal:  Kidney Dis (Basel)       Date:  2020-05-06

Review 8.  Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease.

Authors:  Kathryn Prame Kumar; Alyce J Nicholls; Connie H Y Wong
Journal:  Cell Tissue Res       Date:  2018-01-31       Impact factor: 5.249

9.  Reporting renal biopsies from Cyprus: a systematic approach.

Authors:  Düriye Deren Oygar; Guy H Neild
Journal:  J Nephropathol       Date:  2017-04-13

10.  Protocol and establishment of a Queensland renal biopsy registry in Australia.

Authors:  Joseph Patrick Burke; Manaf Aljishi; Leo Francis; Wendy Hoy; Dakshinamurthy Divi; Roy Cherian; Jeremy Frazier; Glenda Gobe; Pedro Gois; Sridevi Govindarajulu; Sonny Huynh; Shilpanjali Jesudason; George John; Krishan Madhan; Andrew Mallett; Valli Manickam; Clyson Mutatiri; Shu-Kay Ng; Zaw Thet; Peter Trnka; Sree Krishna Venuthurupalli; Dwarakanathan Ranganathan
Journal:  BMC Nephrol       Date:  2020-08-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.